Loading...
Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial
OBJECTIVE: No therapy is known to improve health-related quality of life (HRQL) or dyspnoea in patients with idiopathic pulmonary fibrosis (IPF). This study investigated longitudinal changes in HRQL and dyspnoea and explored the effects of bosentan on these endpoints during the BUILD-1 trial. METHOD...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848824/ https://ncbi.nlm.nih.gov/pubmed/19679600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00188108 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|